3D-QSAR and docking study on 3-benzimidazol-2-ylhydroquinolin-2-one derivatives as VEGFR-2 tyrosine kinase inhibitors
Crossref DOI link: https://doi.org/10.1007/s00044-014-1161-3
Published Online: 2014-07-29
Published Print: 2015-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kang, Cong-min
Liu, Dong-qing
Wang, Xin-yu
Dai, Ying-jie
Cheng, Jia-gao
Lv, Ying-tao
Text and Data Mining valid from 2014-07-29